MyFinsight
Home
Blog
About
Maturities of investments
$31,503K
(-71.55%↓ Y/Y)
Proceeds from issuance of
common stock under the...
$37K
(-68.38%↓ Y/Y)
Proceeds from the
exercise of stock options
$36K
Net cash provided by
investing activities
$23,070K
(60.74%↑ Y/Y)
Net cash provided by
financing activities
$73K
(-37.61%↓ Y/Y)
Canceled cashflow
$8,433K
Net increase
(decrease) in cash, cash...
$2,170K
(118.25%↑ Y/Y)
Canceled cashflow
$20,973K
Purchases of investments
$8,395K
(-91.28%↓ Y/Y)
Purchases of property and
equipment
$38K
(-64.49%↓ Y/Y)
Non-cash lease expense
$6,233K
(272.34%↑ Y/Y)
Stock-based compensation
$3,222K
(-7.68%↓ Y/Y)
Impairment of property and
equipment
$1,625K
Accounts payable and
accrued liabilities
$1,469K
(266.18%↑ Y/Y)
Depreciation and
amortization
$1,257K
(98.26%↑ Y/Y)
Prepaid expenses and
other assets
-$772K
(-467.62%↓ Y/Y)
Net cash used in
operating activities
-$20,973K
(20.43%↑ Y/Y)
Canceled cashflow
$14,578K
Net loss
-$23,693K
(24.62%↑ Y/Y)
Operating lease
liabilities
-$11,691K
(-722.52%↓ Y/Y)
Accretion of investments,
net
$167K
(-88.93%↓ Y/Y)
Back
Back
Cash Flow
Boundless Bio, Inc. (BOLD)
Boundless Bio, Inc. (BOLD)
source: myfinsight.com